METTL3 and breast carcinoma: Furthermore, mining of TIMER database based on TCGA breast cancer samples demonstrated that only the mRNA expression levels of METTL14 and ZC3H13 were also lower in tumor samples (Figure 1G), and there was not any difference of METTL3 and RBM15B (Figure S2).